Artificial Intelligence in Medication Management for Alzheimer's Patients in China

Abstract: This study provides a comprehensive overview of artificial intelligence (AI) in China's pharmaceutical Alzheimer's management by examining past research. The focus is on critical factors that affect medicine adherence and major AI breakthroughs and trends. A systematic analysis examines how artificial intelligence can monitor medication adherence, give reminders, and discover drug interactions. These apps may improve patient adherence, therapeutic efficacy, and quality of life. However, literature gaps emphasise the need for more research. In conclusion, future projects should address these gaps to serve patients better, improve treatment outcomes, and navigate ethical and policy issues, advancing Alzheimer's drug management.

Keywords: Alzheimer's, Artificial Intelligence, Medication Management, Medication Adherence.

DOI: 10.54941/ahfe1004834

Cite this paper:

​